This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Toyota (TM) to Build a $1.22B Electric Vehicle Plant in China
by Zacks Equity Research
Toyota (TM) plans to collaborate with local partner FAW Group and build a new electric vehicle plant in Tianjin.
Adient (ADNT) Up 23.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Auto Stock Roundup: TM Invests in Pony.ai, ADNT Trims View & More
by Zacks Equity Research
While Toyota (TM) steers $400 million to self driving startup Pony.ai, Adient (ADNT) narrows its 2020 view amid coronavirus concerns.
Top Ranked Momentum Stocks to Buy for February 27th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 27th
Adient (ADNT) Trims 2020 Outlook on Coronavirus Outbreak
by Zacks Equity Research
Adient (ADNT) anticipates equity income to be down $175-$185 million in 2020 compared with the prior estimate of $235-$245 million amid the Coronavirus outbreak.
Cooper-Standard (CPS) Reports Loss in Q4, Beats on Revenues
by Zacks Equity Research
Cooper-Standard (CPS) projects current-year sales at $2.85-$3.05 billion.
Is Adient (ADNT) Stock Outpacing Its Auto-Tires-Trucks Peers This Year?
by Zacks Equity Research
Is (ADNT) Outperforming Other Auto-Tires-Trucks Stocks This Year?
Cooper Tire's (CTB) Q4 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Cooper Tire (CTB) expects capital expenditure in the $260-$280 million band for the ongoing year.
Are Investors Undervaluing Adient (ADNT) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Simple Market Timing Strategies That Work - February 19, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Are Options Traders Betting on a Big Move in Adient (ADNT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
Will Adient Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Adient.
Zacks.com featured highlights include: Atlas Air Worldwide, AmerisourceBergen, Murphy USA, Sally Beauty and Adient PLC
by Zacks Equity Research
Zacks.com featured highlights include: Atlas Air Worldwide, AmerisourceBergen, Murphy USA, Sally Beauty and Adient PLC
Moving Average Crossover Alert: Adient
by Zacks Equity Research
Adient plc (ADNT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
5 Stocks That Look Appealing Post Broker Rating Upgrades
by Maharathi Basu
Brokers have a lot more information on a company, at their disposal, and its prospects than individual investors.
ADNT vs. RACE: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADNT vs. RACE: Which Stock Is the Better Value Option?
Adient (ADNT) Tops Q1 Earnings & Sales Estimates, Tweaks View
by Zacks Equity Research
For 2020, Adient (ADNT) projects adjusted EBITDA at $870-$910 million, up from the prior guidance of $820-$860 million.
Adient (ADNT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 209.68% and 2.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Adient (ADNT) This Earnings Season?
by Zacks Equity Research
Adient (ADNT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Truth About Market Timing - January 22, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Can Adient (ADNT) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Adient (ADNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Truth About Market Timing - December 27, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Truth About Market Timing - December 09, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Market Timing Secrets No One Talks About - November 18, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?